Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
791.85
Change Change %
12.95 1.66%

Updated:21 Nov, 2018, 11:29 AM IST

BSE
790.85
Change Change %
12.45 1.60%

Updated:21 Nov, 2018, 11:29 AM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
IDFC
N/A
22-07-2016 Buy 790.00 976.00
N/A
Closed Long (1Y)
22-07-2017

IDFC initiates Aurobindo Pharma with outperform

Aurobindo is now comparable with large-cap peers. Company has superior execution track record in the recent past. Aurobindo's valuation is at 25-30 per cent discount to large-cap peers. The company will give sustained delivery momentum. Large M&A transaction is a key risk to our re-rating thesis.

Top